Literature DB >> 16935228

Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?

Darcy H Wolsey1, Scott A Larson, Donnel Creel, Robert Hoffman.   

Abstract

BACKGROUND: Screening for optic nerve gliomas (ONGs) in children with neurofibromatosis type 1 (NF1) is problematic. Visual acuity (VA) can be unreliable in children. Magnetic resonance imaging is the most sensitive test for ONG, but it is expensive. This study was designed to determine whether visual-evoked potential testing (VEP) is a sensitive and cost-effective screening test for ONG in NF1 in children.
METHODS: We undertook a retrospective review of patients with NF1 at a tertiary care eye center that were born between 1983 and 2003. VA was considered abnormal if 20/40 or worse or more than 2 lines difference between eyes. VEP was abnormal if the P100 was >108 ms (ms) or the interocular difference was greater than 5.0 ms.
RESULTS: Of 297 patients found with NF1, 144 were children and 30 had VEP and MRI. Of those, 14 had ONG and 16 did not. The average P100 of the VEP was 110.5 ms in patients with ONG compared with 103.1 ms (p = 0.004) in those without ONG. VEP was 86% sensitive and 75% specific in detecting ONG. VA was 50% sensitive and 50% specific. Six patients with ONG had normal vision and abnormal VEP. Two subjects had initial abnormal VEP but normal MRI and showed ONG on follow-up imaging. One subject with ONG had a normal VEP initially but subsequent VEP was abnormal.
CONCLUSION: Using serial VEPs, the sensitivity is 93%. Cost of VEP and MRI is $150 and $1750, respectively. VEP is a sensitive and cost-effective screening test for ONG in NF1. VEP may assist in earlier diagnoses of ONG, especially in children with equivocal or difficult ophthalmic examinations.

Entities:  

Mesh:

Year:  2006        PMID: 16935228     DOI: 10.1016/j.jaapos.2006.02.004

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  16 in total

Review 1.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

2.  Retinal nerve fiber layer thickness in children with optic pathway gliomas.

Authors:  Robert A Avery; Grant T Liu; Michael J Fisher; Graham E Quinn; Jean B Belasco; Peter C Phillips; Maureen G Maguire; Laura J Balcer
Journal:  Am J Ophthalmol       Date:  2011-01-12       Impact factor: 5.258

Review 3.  Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.

Authors:  C Van Mierlo; W Spileers; E Legius; I Casteels; C Cassiman
Journal:  Doc Ophthalmol       Date:  2013-07-25       Impact factor: 2.379

4.  Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1.

Authors:  Pinar Topcu-Yilmaz; Burcu Kasim; Hayyam Kiratli
Journal:  Jpn J Ophthalmol       Date:  2014-02-04       Impact factor: 2.447

5.  Handheld optical coherence tomography during sedation in young children with optic pathway gliomas.

Authors:  Robert A Avery; Eugene I Hwang; Hiroshi Ishikawa; Maria T Acosta; Kelly A Hutcheson; Domiciano Santos; Dina J Zand; Lindsay B Kilburn; Kenneth N Rosenbaum; Brian R Rood; Joel S Schuman; Roger J Packer
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

Review 6.  Ophthalmological assessment of children with neurofibromatosis type 1.

Authors:  Catherine Cassiman; Eric Legius; Werner Spileers; Ingele Casteels
Journal:  Eur J Pediatr       Date:  2013-05-25       Impact factor: 3.183

7.  Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.

Authors:  Patrícia de Freitas Dotto; Adriana Berezovsky; Andrea Maria Cappellano; Nasjla Saba da Silva; Paula Yuri Sacai; Frederico Adolfo B Silva; Arthur Gustavo Fernandes; Daniel Martins Rocha; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2018-05-15       Impact factor: 2.379

Review 8.  Optic pathway gliomas: a review.

Authors:  Iris Fried; Uri Tabori; Tarik Tihan; Arun Reginald; Eric Bouffet
Journal:  CNS Oncol       Date:  2013-03

9.  Electrophysiological monitoring in a patient with an optic nerve glioma.

Authors:  Phillip Moradi; Anthony G Robson; Geoffrey E Rose; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2008-02-27       Impact factor: 2.379

10.  Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.

Authors:  Manju Jayaraman; Rashmin Anilkumar Gandhi; Priya Ravi; Parveen Sen
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.